Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients

Fibroblast growth factor 21 (FGF21) is identified as a potential biomarker for liver diseases. However, information is limited regarding serum FGF21 and impaired liver function in hyperthyroidism. We aim to determine the potential association of serum FGF21 levels with impaired liver enzymes in hype...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Endocrinol (Lausanne)
Hlavní autoři: Xiao, Fangsen, Zeng, Jinyang, Huang, Peiying, Yan, Bing, Zeng, Xin, Liu, Changqin, Shi, Xiulin, Wang, Liying, Song, Haiqu, Lin, Mingzhu, Yang, Shuyu, Li, Zhibin, Li, Xuejun, Liu, Chao
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6339876/
https://ncbi.nlm.nih.gov/pubmed/30692965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00800
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky